{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:17:14Z","timestamp":1787829434808,"version":"build-2784847793"},"reference-count":24,"publisher":"Centers for Disease Control and Prevention - Preventing Chronic Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prev. Chronic Dis."],"DOI":"10.5888\/pcd17.190359","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T19:43:55Z","timestamp":1582919035000},"source":"Crossref","is-referenced-by-count":45,"title":["Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV"],"prefix":"10.5888","volume":"17","author":[{"given":"Chinyere","family":"Okoli","sequence":"first","affiliation":[{"name":"ViiV Healthcare, Brentford Middlesex, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"de los Rios","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Eremin","sequence":"additional","affiliation":[{"name":"AIDS Center Foundation, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Brough","sequence":"additional","affiliation":[{"name":"UK CAB and Positively UK, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Young","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Short","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Brentford Middlesex, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54162","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"issue":"10073","key":"key-10.5888\/pcd17.190359-202002250728-R1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(17)30187-3","article-title":"Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.","volume":"389","author":"Shiels","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/dyv352","article-title":"The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009\u201311.","volume":"45","author":"Lesko","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"8","key":"key-10.5888\/pcd17.190359-202002250728-R3","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"issue":"8","key":"key-10.5888\/pcd17.190359-202002250728-R4","doi-asserted-by":"publisher","first-page":"e0160460","DOI":"10.1371\/journal.pone.0160460","article-title":"Cause-Specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy.","volume":"11","author":"Trickey","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12879-019-4184-z","article-title":"Clusterization of comorbidities and multi-morbidities among persons living with HIV: a cross-sectional study.","volume":"19","author":"Maggi","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/apc.2012.0329","article-title":"Comorbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life.","volume":"27","author":"Rodriguez-Penney","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.5888\/pcd17.190359-202002250728-R7","unstructured":"World Health Organization. Constitution. https:\/\/www.who.int\/about\/who-we-are\/constitution. Accessed September 19, 2019."},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","article-title":"Beyond viral suppression of HIV \u2014 the new quality of life frontier.","volume":"14","author":"Lazarus","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2049-3258-72-40","article-title":"What determines health-related quality of life among people living with HIV: an updated review of the literature.","volume":"72","author":"Degroote","year":"2014","journal-title":"Arch Public Health"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions.","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAD.0000000000001685","article-title":"Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy.","volume":"32","author":"Siefried","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12877-018-0789-0","article-title":"The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65\u201374 years and more than 75 years.","volume":"18","author":"Guaraldi","year":"2018","journal-title":"BMC Geriatr"},{"issue":"6","key":"key-10.5888\/pcd17.190359-202002250728-R13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/QAD.0000000000001756","article-title":"Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.","volume":"32","author":"Justice","year":"2018","journal-title":"AIDS"},{"issue":"11","key":"key-10.5888\/pcd17.190359-202002250728-R14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2147\/CIA.S108072","article-title":"Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.","volume":"11","author":"Gimeno-Gracia","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"3","key":"key-10.5888\/pcd17.190359-202002250728-R15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jgs.12695","article-title":"Polypharmacy, drug\u2013drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.","volume":"62","author":"Greene","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"key-10.5888\/pcd17.190359-202002250728-R16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy.","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"},{"issue":"2","key":"key-10.5888\/pcd17.190359-202002250728-R17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40271-016-0195-7","article-title":"A review of HIV-specific patient-reported outcome measures.","volume":"10","author":"Engler","year":"2017","journal-title":"Patient"},{"issue":"8","key":"key-10.5888\/pcd17.190359-202002250728-R18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/hiv.12758","article-title":"Towards person-centered care for people living with HIV: what core outcomes matter, and how might we assess them? A cross-national multi-centre qualitative study with key stakeholders.","volume":"20","author":"Bristowe","year":"2019","journal-title":"HIV Med"},{"key":"key-10.5888\/pcd17.190359-202002250728-R19","unstructured":"HIV.gov. National HIV\/AIDS strategy. https:\/\/www.hiv.gov\/federal-response\/national-hiv-aids-strategy\/overview. Accessed September 19, 2019."},{"key":"key-10.5888\/pcd17.190359-202002250728-R20","first-page":"749","article-title":"Polypharmacy in the HIV-infected older adult population.","volume":"8","author":"Gleason","year":"2013","journal-title":"Clin Interv Aging"},{"key":"key-10.5888\/pcd17.190359-202002250728-R21","unstructured":"US Department of Health and Human Services. AIDS Info. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. https:\/\/aidsinfo.nih.gov\/guidelines\/html\/1\/adult-and-adolescent-arv\/11\/what-to-start. Accessed September 19, 2019."},{"issue":"1","key":"key-10.5888\/pcd17.190359-202002250728-R22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jpm.12431","article-title":"Potential drug\u2013drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.","volume":"25","author":"Castilho","year":"2018","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"key-10.5888\/pcd17.190359-202002250728-R23","doi-asserted-by":"publisher","first-page":"5728957","DOI":"10.1155\/2018\/5728957","article-title":"Evaluation of potential drug\u2013drug interactions with medications prescribed to geriatric patients in a tertiary care hospital.","volume":"2018","author":"Shetty","year":"2018","journal-title":"J Aging Res"},{"issue":"10","key":"key-10.5888\/pcd17.190359-202002250728-R24","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s11606-013-2449-6","article-title":"Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.","volume":"28","author":"Holtzman","year":"2013","journal-title":"J Gen Intern Med"}],"container-title":["Preventing Chronic Disease"],"original-title":[],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T19:43:58Z","timestamp":1582919038000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/pcd\/issues\/2020\/19_0359.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":24,"URL":"https:\/\/doi.org\/10.5888\/pcd17.190359","relation":{},"ISSN":["1545-1151"],"issn-type":[{"value":"1545-1151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"article-number":"190359"}}